PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 138 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $384,615 | +19.8% | 11,100 | 0.0% | 0.00% | – |
Q1 2024 | $321,123 | -35.1% | 11,100 | -48.4% | 0.00% | -100.0% |
Q1 2023 | $494,500 | +110.8% | 21,500 | 0.0% | 0.00% | – |
Q4 2022 | $234,565 | -81.9% | 21,500 | -86.9% | 0.00% | -100.0% |
Q2 2022 | $1,298,000 | -58.7% | 164,075 | +23.6% | 0.00% | -50.0% |
Q1 2022 | $3,144,000 | -31.8% | 132,734 | -1.5% | 0.00% | -33.3% |
Q4 2021 | $4,611,000 | +429.4% | 134,793 | +174.1% | 0.00% | +200.0% |
Q3 2021 | $871,000 | -73.9% | 49,171 | -33.8% | 0.00% | -66.7% |
Q2 2021 | $3,333,000 | +73.3% | 74,260 | 0.0% | 0.00% | +50.0% |
Q1 2021 | $1,923,000 | +28.4% | 74,260 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $1,498,000 | +3.2% | 74,260 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $1,452,000 | +8.5% | 74,260 | -2.0% | 0.00% | 0.0% |
Q2 2020 | $1,338,000 | +85.8% | 75,790 | -25.8% | 0.00% | +100.0% |
Q1 2020 | $720,000 | +42.0% | 102,098 | +41.8% | 0.00% | – |
Q4 2019 | $507,000 | -63.4% | 72,001 | -36.4% | 0.00% | -100.0% |
Q3 2019 | $1,385,000 | -7.9% | 113,276 | -8.7% | 0.00% | 0.0% |
Q2 2019 | $1,503,000 | +55.4% | 124,090 | +61.3% | 0.00% | 0.0% |
Q1 2019 | $967,000 | – | 76,915 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $84,864,191 | 21.18% |
Cannon Global Investment Management, LLC | 69,900 | $2,422,035 | 11.28% |
ADAR1 Capital Management, LLC | 1,603,932 | $55,576,244 | 10.49% |
Checkpoint Capital L.P. | 355,000 | $12,300,750 | 7.42% |
Fairmount Funds Management LLC | 931,890 | $32,289,989 | 3.65% |
BVF INC/IL | 3,319,290 | $115,013,399 | 3.22% |
RTW INVESTMENTS, LP | 5,286,404 | $183,173,899 | 2.84% |
Kynam Capital Management, LP | 800,000 | $27,720,000 | 2.14% |
683 Capital Management, LLC | 604,449 | $20,944,158 | 1.58% |
Birchview Capital, LP | 48,000 | $1,663,200 | 1.54% |